H.B. Fuller: Two Activists, Two Rejected Bids and a Board That Started Buying
Ancora and Engine built their stakes, all eight independent directors bought shares, and the stock closed at a 52-week low on November 20. What the filings show, and the dates that matter over the next five months.
Disclosure: I do not own shares or options in H.B. Fuller, and I am not being paid by the company.
01Why This Stock
H.B. Fuller is a St. Paul, Minnesota maker of industrial adhesives, the glues and sealants that go into diapers, packaging, car parts, electronics and roofs. It had $3.47 billion of revenue in fiscal 2025, and its products are usually less than 2% of the cost of whatever they end up in. It is not a household name, and for most of the past four years it has not been a growth story either: revenue has been flat to down since fiscal 2022.
It reached this page because three separate signals lined up in the same quarter. Two activist funds, Ancora and Engine Capital, added heavily to their stakes in the three months to September 30, 2026, and several event-driven hedge funds opened or expanded positions alongside them. Every one of the eight independent directors then bought shares in the open market between September 28 and October 7. And the board has now rejected two cash offers for one of its three businesses, while Ancora has asked it to consider selling the whole company, with a deadline for board nominations opening on December 17.
The stock has not responded. It closed at $46.24 on November 20, 2026, its lowest close of the past year, and is down about 28% from its June high. You can follow its holders quarter by quarter on our H.B. Fuller ownership page.
- 1 May 26: Ancora publicly opposes the AMS deal
- 2 June 25: H.B. Fuller agrees to buy AMS with Q2 results
- 3 August 12: Ancora bids $1.1-1.2B for the BAS unit; Engine letter Aug 14
- 4 August 24: Board rejects the first bid
- 5 September 28: Directors start buying; Ancora raises its bid Sep 29
- 6 October 19: Second bid rejected; "market check" announced
- 7 October 27: Ancora calls for a sale of the whole company
- Hedge funds: Ancora roughly 3.8% and Engine roughly 1.7% of the company at September 30, after adding +63.5% and +120.3% in the quarter.
- Insiders: $1.15 million of open-market buying from eight directors and one executive in three weeks, after a public letter from Engine criticised the board for not owning stock.
- Catalysts: a "market check" on parts of the business due by the end of 2026, the nomination window from December 17 to January 16, the AMS deal closing, and fiscal 2027 guidance in January.
- Valuation: about 7.7 times pro forma earnings before interest, tax, depreciation and amortization (EBITDA), against 9 to 11 times in the activists' private-market estimates.
- The catch: volumes are falling, debt will be about four times EBITDA once the AMS deal closes, and free cash flow has fallen three years running.
02The Hedge Funds Behind It
The 13F filings for the quarter to September 30, 2026 show two groups moving in opposite directions. Growth and quality managers cut: Kayne Anderson Rudnick reduced its stake by about a quarter and Fidelity by about a third. Activist and event-driven money went the other way.
Ancora Advisors, the Cleveland firm that has run the public campaign, held 2,056,536 shares at September 30, up +63.5% on the quarter and about 3.82% of the company. Ancora's 13F book runs to roughly 2,200 positions, most of them index-sized, so a stake of this size stands out as a deliberate bet. Engine Capital held 892,947 shares, up +120.3%, about 1.66% of the company; Engine describes itself as owning about 2%, which may include positions that 13F filings do not show. Together the two own roughly 5.5%. Neither has filed a Schedule 13D, which is required only when an investor or a group acting together passes 5%.
Others joined them. Luminus Management more than doubled its stake, to a position worth about 12% of its 13F book. Canyon Capital opened a new position. Millennium Management built its stake from a small one to about 721,000 shares. Among the long-term holders, Neuberger Berman added about 11% and Minnesota-based Mairs & Power trimmed slightly.
Funds on our Smart Money List
| Fund | Signal | Shares, Q3 2026 | Shares, Q2 2026 | Change | Value | % of company |
|---|---|---|---|---|---|---|
| Ancora Holdings | High | 2,056,536 | 1,257,802 | +63.5% | $101.7M | 3.82% |
| Engine Capital | High | 892,947 | 405,349 | +120.3% | $44.2M | 1.66% |
| Millennium Management | Low | 721,020 | 43,505 | +1,557.3% | $35.7M | 1.34% |
| Qube Research & Technologies | Low | 415,436 | 45,545 | +812.1% | $20.6M | 0.77% |
| Canyon Partners | Low | 344,359 | 0 | New | $17.0M | 0.64% |
| Gabelli Funds / GAMCO Investors | Medium | 301,000 | 301,000 | Unchanged | $14.9M | 0.56% |
| Polar Asset Management Partners | Low | 228,000 | 82,800 | +175.4% | $11.3M | 0.42% |
| AQR Capital Management | Low | 174,184 | 110,874 | +57.1% | $8.6M | 0.32% |
| Tudor Investment Corporation | Medium | 164,143 | 0 | New | $8.1M | 0.30% |
| Arrowstreet Capital | Low | 161,894 | 224,784 | -28.0% | $8.0M | 0.30% |
| Citadel Advisors | Low | 142,071 | 30,212 | +370.2% | $10.7M | 0.26% |
| Woodline Partners | Low | 120,479 | 113,479 | +6.2% | $6.0M | 0.22% |
| Two Sigma Investments | Low | 117,903 | 0 | New | $5.8M | 0.22% |
| Susquehanna International Group | Low | 90,908 | 7,912 | +1,049.0% | $5.4M | 0.17% |
| Bridgewater Associates | Low | 72,609 | 3,761 | +1,830.6% | $3.6M | 0.13% |
| Point72 Asset Management | Low | 45,163 | 0 | New | $2.2M | 0.08% |
| Brevan Howard Asset Management | Low | 42,525 | 13,820 | +207.7% | $2.1M | 0.08% |
| Freestone Grove Partners | Low | 23,305 | 5,715 | +307.8% | $1.2M | 0.04% |
| Winton Group | Low | 18,700 | 3,900 | +379.5% | $925K | 0.03% |
| Holocene Advisors | Medium | 17,127 | 0 | New | $847K | 0.03% |
| Balyasny Asset Management | Low | 16,720 | 52,994 | -68.4% | $827K | 0.03% |
| Engineers Gate | Low | 13,620 | 31,603 | -56.9% | $674K | 0.03% |
| Graham Capital Management | Low | 10,818 | 9,567 | +13.1% | $535K | 0.02% |
| Man Group | Low | 6,616 | 0 | New | $327K | 0.01% |
| Magnetar Capital | Low | 6,224 | 30,067 | -79.3% | $308K | 0.01% |
| Capstone Investment Advisors | Low | 5,954 | 6,063 | -1.8% | $295K | 0.01% |
| Marshall Wace | Low | 4,400 | 4,911 | -10.4% | $218K | 0.01% |
| Squarepoint Capital | Low | 0 | 48,284 | Sold out | - | - |
| Adage Capital Management | Low | 0 | 10,000 | Sold out | - | - |
| Voloridge Investment Management | Low | 0 | 94,172 | Sold out | - | - |
| Jane Street Group | Low | 0 | 27,590 | Sold out | - | - |
| ExodusPoint Capital | Low | 0 | 78,919 | Sold out | - | - |
| Verition Fund Management | Low | 0 | 221,045 | Sold out | - | - |
Funds on our Smart Money Fund List that reported FUL at either quarter end. Signal is how closely each fund is followed. Value at the quarter-end price. Source: SEC 13F filings, our warehouse.
Who bought and who sold in Q3 2026
| Manager | Shares added | Change | Shares held | % of company |
|---|---|---|---|---|
| Ancora Holdings Smart Money List | +798,734 | +63.5% | 2,056,536 | 3.82% |
| Millennium Management Smart Money List | +677,515 | +1,557.3% | 721,020 | 1.34% |
| Engine Capital Smart Money List | +487,598 | +120.3% | 892,947 | 1.66% |
| Qube Research & Technologies Smart Money List | +369,891 | +812.1% | 415,436 | 0.77% |
| DIMENSIONAL FUND ADVISORS LP | +345,199 | +12.1% | 3,202,937 | 5.95% |
| Canyon Partners Smart Money List | +344,359 | New | 344,359 | 0.64% |
| PRICE T ROWE ASSOCIATES INC /MD/ | +272,096 | +66.2% | 683,163 | 1.27% |
| NEUBERGER BERMAN GROUP LLC | +258,545 | +10.8% | 2,650,035 | 4.92% |
| LUMINUS MANAGEMENT LLC | +212,760 | +135.0% | 370,316 | 0.69% |
| Lighthouse Investment Partners, LLC | +196,025 | +88.8% | 416,741 | 0.77% |
| Manager | Shares cut | Change | Shares held | % of company |
|---|---|---|---|---|
| COOKE & BIELER LP | -1,105,022 | Sold out | 0 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | -757,460 | -97.1% | 22,585 | 0.04% |
| NORGES BANK | -753,424 | Sold out | 0 | 0.00% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | -690,706 | -98.9% | 7,417 | 0.01% |
| BROWN ADVISORY INC | -652,553 | -88.5% | 85,055 | 0.16% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | -526,841 | -26.3% | 1,474,886 | 2.74% |
| FMR LLC | -353,913 | -32.6% | 731,837 | 1.36% |
| First Eagle Investment Management, LLC | -277,743 | -40.9% | 400,943 | 0.74% |
| Verition Fund Management Smart Money List | -221,045 | Sold out | 0 | 0.00% |
| Capital World Investors | -220,078 | Sold out | 0 | 0.00% |
All 13F filers, Q2 2026 to Q3 2026. Index funds and banks move large blocks for reasons that have nothing to do with the company, so read these with the fund names in mind. Source: SEC 13F filings, our warehouse.
Ownership over time
Short interest was 2.20 million shares, about 5.6% of the float, on October 30, 2026, down from 2.87 million a month earlier (Nexqual). Options traders are pricing a large move: implied volatility on February 2027 contracts was about 63% on November 20, roughly twice the stock's realised volatility over the past 30 days. To check any fund's other holdings, open its page from the tables above, or paste your own tickers into our Portfolio X-ray.
03Insiders Bought the Dip
On August 14, 2026, Engine published a letter saying the only independent director who had bought shares was the chair, Teresa Rasmussen, and that her purchase was more than four years old. Four days later Rasmussen filed an amended Form 4 changing the code on a 1,000-share purchase at $65.83 on April 17, 2026 to an open-market buy. Six weeks after the letter, the directors bought.
Seven directors bought between September 28 and 30 at about $49 to $50 a share, most of them about $100,000 each. R. Jeffrey Bailly, the executive chair of UFP Technologies who joined the board on September 23, bought $500,000 at $50.00 on October 7. Shahbaz Malik, who runs the building adhesives business that Ancora wants to buy, added $25,000 on October 16. The chief executive, Celeste Mastin, made open-market purchases in April 2025 and April 2026, of $198,310 and $295,104.
Two things temper the signal. The buying followed public criticism, so some of it is a response to Engine, and the amounts are modest: after buying, most directors hold 2,000 to 4,000 shares directly. And executives have kept selling. The chief financial officer sold $857,764 in October 2025, and Nathan Weaver, executive vice president for business transformation, sold in November 2025, August 2026 and again on November 11, 2026 at $50.42. Over the two years to November 21, 2026, open-market purchases came to $1,707,377 and sales to $2,678,843. Every trade is listed below, and current filings are on our insider trading pages.
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Nathan D. Weaver | Executive VP, Business Transformation | Sale | 1,200 | $50.42 | $60,510 |
| Oct 16, 2026 | Muhammad Shahbaz Malik | Senior VP, Building Adhesive Solutions | Buy | 478.66 | $52.23 | $25,000 |
| Oct 7, 2026 | R. Jeffrey Bailly | Director | Buy | 10,000 | $50.00 | $500,000 |
| Sep 30, 2026 | Celine Christine Martin | Director | Buy | 464.6 | $49.50 | $22,998 |
| Sep 29, 2026 | Srilata Zaheer | Director | Buy | 40 | $49.97 | $1,999 |
| Sep 29, 2026 | Charles T. Lauber | Director | Buy | 2,005 | $49.87 | $99,985 |
| Sep 29, 2026 | Michael J. Happe | Director | Buy | 2,000 | $49.62 | $99,250 |
| Sep 28, 2026 | Srilata Zaheer | Director | Buy | 2,000 | $49.06 | $98,120 |
| Sep 28, 2026 | Teresa J. Rasmussen | Director (Chair) | Buy | 500 | $48.98 | $24,490 |
| Sep 28, 2026 | Teresa J. Rasmussen | Director (Chair) | Buy | 1,542 | $48.96 | $75,494 |
| Sep 28, 2026 | Thomas W. Handley | Director | Buy | 2,000 | $49.41 | $98,820 |
| Sep 28, 2026 | Daniel L. Florness | Director | Buy | 2,030 | $49.34 | $100,160 |
| Aug 11, 2026 | Nathan D. Weaver | Executive VP, Business Transformation | Sale | 9,561 | $62.06 | $593,332 |
| Apr 17, 2026 | Teresa J. Rasmussen | Director (Chair) | Buy | 1,000 | $65.83 | $65,830 |
| Apr 7, 2026 | Celeste Beeks Mastin | President and CEO | Buy | 5,170 | $57.08 | $295,104 |
| Nov 13, 2025 | Nathan D. Weaver | Executive VP, Business Transformation | Sale | 7,075 | $58.38 | $413,018 |
| Oct 27, 2025 | John J. Corkrean | Executive VP and CFO | Sale | 14,222 | $60.31 | $857,764 |
| Sep 26, 2025 | James J. East | Executive VP, HHC | Buy | 31 | $58.62 | $1,817 |
| Aug 8, 2025 | Joao Magalhaes | Senior VP, Engineering Adhesives | Sale | 1,099 | $56.31 | $61,890 |
| Aug 7, 2025 | Joao Magalhaes | Senior VP, Engineering Adhesives | Sale | 1,046 | $56.20 | $58,788 |
| Jul 10, 2025 | Robert J. Martsching | VP, Corporate Controller | Sale | 9,546 | $64.30 | $613,852 |
| Apr 1, 2025 | Celeste Beeks Mastin | President and CEO | Buy | 3,500 | $56.66 | $198,310 |
| Jan 28, 2025 | Xinyu Du | Senior VP, Global R&D | Sale | 69 | $63.68 | $4,394 |
| Jan 27, 2025 | Xinyu Du | Senior VP, Global R&D | Sale | 240 | $63.73 | $15,295 |
Open-market purchases and sales only (Form 4 codes P and S), November 2024 to November 21, 2026. Option exercises, tax withholding and grants are left out. Each value links to the SEC filing. Download the trades (CSV)
04The Activist Campaign, Step by Step
| 2026 | What happened | Source |
|---|---|---|
| May 26 | Ancora publicly opposes H.B. Fuller's pursuit of Advanced Medical Solutions (AMS), a UK wound-care company, and asks for a strategic review that includes a sale. | BusinessWire |
| Jun 10 | Engine writes privately to oppose the deal, valuing AMS at about 15.5 times EBITDA against about 8 times for H.B. Fuller. | Engine |
| Jun 24-25 | H.B. Fuller announces the AMS purchase with its second-quarter results and raises guidance. Ancora condemns the deal; Engine says the stock fell about 11% over the next five days. | BusinessWire |
| Aug 12 | Ancora makes a public cash offer of $1.1 billion to $1.2 billion for the Building Adhesive Solutions (BAS) business, with no financing condition. | BusinessWire |
| Aug 14 | Engine publishes its letter, asking for market checks on BAS and on the whole company. | Engine |
| Aug 24 | The board rejects the first offer; Ancora reaffirms it. | BusinessWire |
| Sep 23 | Director Ruth Kimmelshue resigns; R. Jeffrey Bailly joins the board. | 8-K |
| Sep 29 | Ancora raises its offer to $1.2 billion to $1.4 billion, backed by a "highly confident" financing letter from Fortress, and puts the price at 8.5 to 9.9 times BAS earnings. | BusinessWire |
| Oct 19 | The board unanimously rejects the second offer and announces a "market check" for select segments and product lines it considers less central, with any proceeds used to cut debt, to be completed by the end of 2026. | 8-K |
| Oct 27 | Ancora asks the board to run a full review of strategic alternatives, including a sale of the entire company, and says it is reserving its rights on "upcoming deadlines" and on making an offer for the whole of H.B. Fuller. | BusinessWire |
| Nov 16 | The corporate controller resigns, staying through January 2027. | 8-K |
The "upcoming deadlines" are almost certainly the nomination window for the 2027 annual meeting. Under the company's bylaws, shareholders who want to nominate directors must give notice between December 17, 2026 and January 16, 2027 (2026 proxy statement). As of November 21, 2026 there was no Schedule 13D, proxy filing or nomination notice from either fund on EDGAR, and no settlement had been announced.
Any contest has limits. The board is classified: its nine directors serve staggered three-year terms, so only three seats (Thomas Handley, Srilata Zaheer and Bailly) are up at the 2027 meeting. Even a clean sweep would not give the activists a majority. That makes a settlement, such as new directors and a review committee, the outcome activists often reach in situations like this, and Ancora has signed cooperation agreements with other companies before.
05The Business
H.B. Fuller reports three businesses. Hygiene, Health and Consumable (HHC) supplies adhesives for diapers and other nonwovens, packaging, tapes, labels and, increasingly, medical products. Engineering Adhesives (EA) serves electronics, cars, aerospace and solar. Building Adhesive Solutions (BAS) sells roofing adhesives, construction sealants and insulating-glass materials, and is the unit Ancora has bid for.
Third-quarter results, for the quarter ended August 29, 2026, show the pattern of the past two years. Revenue rose 5.2% to $938.2 million and adjusted earnings per share rose 21% to $1.52, ahead of the $1.46 analysts expected. But all of the growth came from higher prices: volumes fell 3.0%, and fell in every business.
| FY2023 | FY2024 | FY2025 | Last 12 months | |
|---|---|---|---|---|
| Net revenue | $3,510.9M | $3,568.7M | $3,473.6M | ~$3,554M |
| Adjusted EBITDA | ~$581M | $593.9M | $620.7M | ~$657M |
| Adjusted EBITDA margin | 16.5% | 16.6% | 17.9% | ~18.5% |
| Operating cash flow | $378.4M | $302.4M | $263.5M | - |
| Capital spending | $119.1M | $139.2M | $142.3M | - |
| Free cash flow | $259.3M | $163.2M | $121.2M | ~$100M |
Sources: fiscal 2025 10-K, third-quarter 10-Q, third-quarter results. Last-twelve-month free cash flow is an estimate from Nexqual's SEC-derived tables.
Margins have risen about 2.5 percentage points since fiscal 2023 through price increases, a better mix and cost cuts, and the company has beaten analysts' earnings estimates four quarters running. Free cash flow has gone the other way, from $259 million in fiscal 2023 to about $100 million over the latest twelve months, as working capital grew: customers took 63 days to pay against 58 a year earlier, and inventory rose to 88 days from 78.
Guidance for fiscal 2026, which ends November 28, is adjusted EBITDA of $655 million to $670 million and adjusted earnings per share of $4.70 to $4.85. That implies $1.20 to $1.35 for the fourth quarter, below the $1.36 analysts expect (Nexqual), and estimates for fiscal 2027 have been cut from $5.32 to $5.15 over the past 90 days.
06Debt and the AMS Deal
The AMS purchase is the reason the activists went public. H.B. Fuller agreed to pay 285 pence a share in cash, about $892 million for the equity and about 15.5 times AMS's 2026 EBITDA by Engine's count, a 35% premium. AMS shareholders approved it on August 12 (84.2% in favour), most regulators have cleared it, and the company expects to complete it in the fourth quarter of calendar 2026. The deal must close by June 25, 2027.
To pay for it, H.B. Fuller sold $850 million of 7.625% notes due 2034 in October and is extending and enlarging its term loan. The company's own pro forma figures show what that does to the balance sheet:
| August 29, 2026 (actual) | After AMS (pro forma) | |
|---|---|---|
| Cash | $97M | $118M |
| Total debt | $2,055M (3.1x) | $3,097M (4.3x) |
| Net debt | $1,957M (3.0x) | $2,979M (4.2x) |
| Last-12-month adjusted EBITDA | $657M | $713M |
Multiples are net debt or debt divided by last-twelve-month adjusted EBITDA. Source: October 6, 2026 investor presentation; note terms from the October 22, 2026 8-K.
Management says leverage will be about 4.0 times at closing and that it intends to reduce it over two years. The covenants are not the constraint: secured debt was 2.2 times EBITDA at August 29 against a limit of 4.5 times. The pressure comes from the cost: the new notes alone carry about $65 million a year of interest, and the 7.625% coupon shows what lenders now charge this company. Getting back to the 2.5 to 3.0 times that Ancora and, earlier, management talked about would take $0.8 billion to $1.1 billion of debt repayment, several years of free cash flow at recent levels. That is why asset sales sit at the centre of the debate: selling BAS for $1.2 billion to $1.4 billion would bring leverage down to about 2.9 times by my estimate, before any tax on the sale.
If AMS does not close by June 25, 2027 (extendable to October 21, 2027), $450 million of the new notes must be redeemed at par.
07What It Could Be Worth
At $46.24 the company is worth about $2.49 billion in the market. Adding the pro forma net debt of $2.98 billion gives an enterprise value of about $5.47 billion, or 7.7 times pro forma EBITDA of $713 million (6.8 times before AMS). Ancora puts its BAS offer at 8.5 to 9.9 times that unit's earnings, and Engine estimates the whole company would sell for 9 to 11 times. Adhesive deals over the past decade have mostly been struck at 11 to 15 times or more.
| Year | Deal | Price | Multiple of EBITDA |
|---|---|---|---|
| 2017 | H.B. Fuller buys Royal Adhesives & Sealants (8-K) | $1.575B | 11.4x |
| 2021-22 | Arkema buys Ashland Performance Adhesives (Ashland) | $1.65B | ~20x |
| 2021-23 | Sika buys MBCC (Sika) | CHF ~5.5B | 11.5x |
| 2026 | H.B. Fuller agrees to buy AMS (Engine's estimate) | ~GBP 715M | ~15.5x |
| 2026 | Ancora's rejected offer for BAS | $1.2-1.4B | 8.5-9.9x |
| Nov 20, 2026 | H.B. Fuller in the stock market, pro forma | $5.47B | 7.7x |
A sum-of-the-parts estimate values each business separately and subtracts the debt. Because debt is large next to the market value, each turn of EBITDA multiple is worth about $13.25 a share, which is why the cases spread so widely.
| Business | Last-12-month EBITDA | Bear | Base | Bull |
|---|---|---|---|---|
| Hygiene, Health and Consumable | $266.6M | 6.5x | 8.0x | 10.0x |
| Engineering Adhesives | $243.3M | 7.5x | 9.0x | 11.0x |
| Building Adhesive Solutions | $141.0M | 6.5x | 8.5x | 9.9x |
| AMS | $57M | 9x | 11x | 13x |
| Enterprise value | $4,738M | $6,148M | $7,479M | |
| Value per share | $32.68 | $58.88 | $83.62 |
The bear case also cuts every business's EBITDA by 5% for a volume recession. The base multiple for BAS is close to the low end of Ancora's offer and the bull multiple matches the high end. Download the calculation (CSV)
Wall Street's view is less dramatic: six of the seven analysts who cover the stock rate it a buy, with an average target of $66.29, but five of them cut their targets between September 25 and October 21, 2026 (Nexqual).
08Dates to Watch
| Date | Event | Why it matters |
|---|---|---|
| November 28, 2026 | Fiscal 2026 ends | Sets the base for fiscal 2027 guidance |
| By December 31, 2026 | Result of the "market check" on select segments and product lines | Size of any sale and how much debt it repays |
| Fourth quarter of 2026 | AMS completion (court sanction date not yet announced) | Leverage rises to about 4 times |
| December 17, 2026 to January 16, 2027 | Nomination window for the 2027 annual meeting | Proxy fight or settlement |
| Mid-January 2027 (expected) | Fourth-quarter results and fiscal 2027 guidance | Last year's report came on January 14 |
| February 15, 2027 | $300 million of 4% notes mature | Already covered by the AMS financing |
| April 2027 (expected) | Annual meeting; three board seats up | The 2026 meeting was on April 16 |
| June 25, 2027 | Deadline for AMS to close | $450 million of notes redeemed if it does not |
09Risks
- Volume. Volumes fell 3.0% in the third quarter and 3.3% over nine months, in every business. If price increases fade while volumes keep falling, the margin gains reverse.
- Debt. About 4 times EBITDA after AMS, with $850 million at 7.625%.
- Cash. Free cash flow of about $100 million over the past twelve months, with restructuring spending continuing into fiscal 2028.
- AMS. A cross-border deal at about 15.5 times EBITDA; AMS's US LiquiBand sales fell 15% in the first half of 2026.
- The board can wait. With a classified board, a single proxy contest cannot change control, and the October 19 rejection was unanimous.
- The activists own about 5.5%. A settlement could add directors without changing the strategy.
- Expectations. Analysts' fourth-quarter estimate sits above the top of what guidance implies.
- A settlement with no commitment to a strategic review or a meaningful asset sale.
- Fiscal 2027 guidance with volumes down again and margins under pressure.
- A credit rating downgrade, a dividend cut or another large acquisition.
- On the other side: a Schedule 13D, director nominations, a sale of BAS or another unit at 9 times or more, or an offer for the whole company.
10How It Scores
Every Hedge Fund Highlight is scored out of 100 on the same five tests, so reports can be compared over time.
| Test | Weight | Score | Why |
|---|---|---|---|
| Hedge fund buying | 25 | 20 | Ancora and Engine added heavily; Luminus, Canyon, Millennium and others joined. Fidelity and Kayne cut. |
| Insider buying | 20 | 12 | All eight independent directors and one executive bought, but after public criticism, in small amounts, while executives sold. |
| Business momentum | 20 | 9 | Earnings beats from price and margin; volumes down, free cash flow down, estimates cut. |
| Catalysts | 20 | 17 | Two rejected bids, a call for a sale, a market check due by year end and a nomination window from December 17. |
| Valuation and risk | 15 | 10 | 7.7 times pro forma EBITDA against 9 to 11 times in private-market estimates, offset by leverage. |
| Total | 100 | 68 |
11How I Put This Together
Hedge Fund Highlight stocks come from a weekly screen of the roughly 270 funds on our Smart Money Fund List: stocks that several of them bought in the latest 13F quarter, checked for open-market insider buying (Form 4), activist stakes (Schedule 13D) and the state of the business from SEC financial data. The tables of funds and the ownership charts in section 02 are drawn from the same 13F warehouse as the rest of this section and update when new filings arrive; the rest of the report is as of the dates shown.
Company figures come from H.B. Fuller's SEC filings (10-K, 10-Q, proxy) and its October 6, 2026 investor presentation. Activist statements are from the funds' own releases and letters. Market data (short interest, options, analyst targets and estimates, peer valuations) is from Nexqual at the November 20, 2026 close. Insider trades were read from each Form 4 on EDGAR. The sum-of-the-parts values, leverage paths and the score are my own calculations and judgement. Where a figure could not be confirmed from a filing it was left out.
12Corrections and Updates
- November 21, 2026: First published, with prices at the November 20, 2026 close.
This report is research drawn from public filings and is not investment advice or a recommendation to buy or sell any security. I do not own shares or options in H.B. Fuller, and I am not being paid by the company. 13F filings show long US equity positions at each quarter end and are filed up to 45 days later; they do not show short positions or most derivatives, so a fund's full exposure can differ.
